The use of live biotherapeutic products is a developing strategy to treat challenging diseases. Administration of one such drug, called VE303, could become successful against recurrent C. difficile infections.
The ironic role of orally administered antibiotics: savior or destroyer of our gut?
Your Best Friend’s #2 could be your #1 solution to fight C-Diff infections; exploring the success of fecal transplantation for the treatment of recurrent C Diff infection.
Antibiotic resistance has been the hot topic of the current century. Recent research has shown that microbial interactions can modulate the susceptibility of bacteria to antibiotics.
Microbes can undergo changes in their genetic composition. Mobile Genetic Elements can facilitate these changes. Is this just another travel route for the spread of antibiotic resistance genes?
Antibiotics have revolutionized the treatment of deadly infectious diseases, but does that mean that these diseases are only a thing of the past?
Scientists analyzed the “collateral damage” of antibiotics on our gut microbiome and identified potential antidotes to protect our gut bacteria.
From one tissue environment to the next, pathogens are challenged and react in different ways. Researchers have found two novel mechanisms by which the microbiota and immune system interact to protect against antibiotic-resistant pathogens.